Turning Scientific Insight into Therapeutic Impact

Neurimmune's teams of scientists, researches and clinical experts are committed to delivering advanced therapies by focusing on science-driven discoveries and early clinical development of novel drug candidates.

Our mission is to advance breakthrough science to transform the treatment of protein misfolding diseases. By combining deep expertise in amyloid biology with innovative therapeutic approaches, we strive to develop medicines that directly target and remove pathogenic protein deposits in the brain, the heart and other peripheral organs. Through rigorous research and clinical excellence, we aim to deliver medical breakthroughs to patients, improving outcomes by restoring organ function.

After antibiotics, antivirals, and targeted cancer therapies, we are entering a new era in medicine by targeting and depleting misfolded proteins that drive chronic protein aggregation diseases.

Roger M. Nitsch, CEO